Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine butylbromide for abdominal pain and cramping
NCT02242292Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hyoscine butylbromide in abdominal pain, abdominal cramping, sponsored by Boehringer Ingelheim. Started Apr 2006; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
abdominal painabdominal cramping
Beyond the preview
Go deeper on NCT02242292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242292.